Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

DEVELOPMENT AND STABILITY EVALUATION OF ATORVASTATIN EXTEMPORANEOUS ORAL SUSPENSION FOR ELDERLY PATIENTS

View through CrossRef
Objective: This study aims to develop an extemporaneous oral suspension formulation of atorvastatin (ATV) and evaluate its stability. Methods: ATV extemporaneous oral suspension was developed by preparation using different suspension vehicles. The developed formulation was stored at ambient temperature (30±2 °C) and refrigerated temperature (4±2 °C) to evaluate its physical and chemical stability. The formulation was also exposed to 3% hydrogen peroxide (H2O2), 1 M hydrochloric acid (HCl), and 1 M sodium hydroxide (NaOH) to evaluate its stability under stress conditions. ATV was analyzed using High-Performance Liquid Chromatography (HPLC), which was validated prior to use. Results: A vehicle containing 0.6% sodium carboxymethyl cellulose (SCMC) was suitable for the preparation of ATV extemporaneous oral suspension. The HPLC method was found to have linearity covering the range of 10–100 mg/ml with a correlation coefficient (r) greater than 0.99. Accuracy and precision were in the range of 99–110% and below 11 %RSD, respectively. The pH and viscosity of the developed formulation stored under ambient and refrigerated temperatures did not differ over 7 d, while the re-dispersibility time of the formulation stored in refrigerator shifted to higher more slowly than the formulation stored at ambient temperature. The % ATV remaining over 7 d was 92.02–106.67% at 30±2 °C and 99.64–107.58% at 4±2 °C. After being subjected to stress conditions, ATV remained stable under oxidation and alkaline conditions, while it significantly degraded under acidic conditions, remaining 24.27%. Conclusion: The developed ATV extemporaneous oral suspension using a suspension vehicle containing 0.6% SCMC was chemically stable for at least 7 d at 30±2 °C and 4±2 °C. However, this formulation should be preferably stored at refrigerator temperature for use within 7 d to maintain both chemical and physical stability. The formulation was not stable under acid-stress conditions.
Title: DEVELOPMENT AND STABILITY EVALUATION OF ATORVASTATIN EXTEMPORANEOUS ORAL SUSPENSION FOR ELDERLY PATIENTS
Description:
Objective: This study aims to develop an extemporaneous oral suspension formulation of atorvastatin (ATV) and evaluate its stability.
Methods: ATV extemporaneous oral suspension was developed by preparation using different suspension vehicles.
The developed formulation was stored at ambient temperature (30±2 °C) and refrigerated temperature (4±2 °C) to evaluate its physical and chemical stability.
The formulation was also exposed to 3% hydrogen peroxide (H2O2), 1 M hydrochloric acid (HCl), and 1 M sodium hydroxide (NaOH) to evaluate its stability under stress conditions.
ATV was analyzed using High-Performance Liquid Chromatography (HPLC), which was validated prior to use.
Results: A vehicle containing 0.
6% sodium carboxymethyl cellulose (SCMC) was suitable for the preparation of ATV extemporaneous oral suspension.
The HPLC method was found to have linearity covering the range of 10–100 mg/ml with a correlation coefficient (r) greater than 0.
99.
Accuracy and precision were in the range of 99–110% and below 11 %RSD, respectively.
The pH and viscosity of the developed formulation stored under ambient and refrigerated temperatures did not differ over 7 d, while the re-dispersibility time of the formulation stored in refrigerator shifted to higher more slowly than the formulation stored at ambient temperature.
The % ATV remaining over 7 d was 92.
02–106.
67% at 30±2 °C and 99.
64–107.
58% at 4±2 °C.
After being subjected to stress conditions, ATV remained stable under oxidation and alkaline conditions, while it significantly degraded under acidic conditions, remaining 24.
27%.
Conclusion: The developed ATV extemporaneous oral suspension using a suspension vehicle containing 0.
6% SCMC was chemically stable for at least 7 d at 30±2 °C and 4±2 °C.
However, this formulation should be preferably stored at refrigerator temperature for use within 7 d to maintain both chemical and physical stability.
The formulation was not stable under acid-stress conditions.

Related Results

PENGARUH KUALITAS HIDUP LANSIA TERHADAP RISIKO ELDERLY ABUSE: SYSTEMATIC REVIEW AND META ANALYSIS
PENGARUH KUALITAS HIDUP LANSIA TERHADAP RISIKO ELDERLY ABUSE: SYSTEMATIC REVIEW AND META ANALYSIS
Latar belakang: Negara Indonesia saat ini mulai memasuki periode aging population. Diproyeksikan tahun 2035 mencapai 48,2 juta jiwa 15,77%, lebih tinggi dari angka global pada angk...
e0034 Inhibition of atorvastatin on the autophagy of vascular endothelial cells
e0034 Inhibition of atorvastatin on the autophagy of vascular endothelial cells
Objective To explore the mechanism of atorvastatin's protection on vascular endothelial cells, we conducted the research of impact of atorvastatin on vascular end...
Comparison Between Atorvastatin and Rosuvastatin on Anti- Thrombogenic Effect in Patients with Hyperlipidemia
Comparison Between Atorvastatin and Rosuvastatin on Anti- Thrombogenic Effect in Patients with Hyperlipidemia
Background: Atorvastatin and rosuvastatin are two widely used HMG-CoA reductase inhibitors (statins). These are used as lipid-lowering drugs to reduce atherosclerosis-induced cardi...
e0468 Effect of different loading doses of atorvastatin on percutaneous coronary intervention for acute coronary syndromes
e0468 Effect of different loading doses of atorvastatin on percutaneous coronary intervention for acute coronary syndromes
Background Percutaneous coronary intervention (PCI)-induced myocardial damage is a major cause of late cardiovascular events. Treatment with atorvastatin before P...
The Effect of Cytochrome P450 and Organic Anion Transporter Polypeptide on Macrolides–Atorvastatin Drug Interaction
The Effect of Cytochrome P450 and Organic Anion Transporter Polypeptide on Macrolides–Atorvastatin Drug Interaction
Cytochrome P450 (CYP3A4) enzymes and organic anion-transporting polypeptides (OATPs) are critical in drug pharmacokinetics. Fifteen rabbits were divided into three groups: the ator...

Back to Top